A framework for cost-effectiveness analysis from clinical trial data

被引:65
|
作者
O'Hagan, A
Stevens, JW
机构
[1] Univ Sheffield, Dept Probabil & Stat, Stat Serv Unit, Sheffield S3 7RH, S Yorkshire, England
[2] Astra Zeneca R&D Charnwood, Loughborough, Leics, England
关键词
Bayesian analysis; cost-effectiveness acceptability curve; log-normal distribution; net benefit; normal distribution; outcomes;
D O I
10.1002/hec.617
中图分类号
F [经济];
学科分类号
02 ;
摘要
We present a general Bayesian framework for cost-effectiveness analysis (CEA) from clinical trial data. This framework allows for very flexible modelling of both cost and efficacy related trial data. A common CEA technique is established for this wide class of models through linking mean efficacy and mean cost to the parameters of any given model. Examples are given in which efficacy may be measured as a continuous, binary, ordinal or time-to-event outcome, and in which costs are modelled as distributed normally, log-normally, as a mixture or non-parametrically. A case study is presented, illustrating the methodology and illuminating the role of prior information. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:303 / 315
页数:13
相关论文
共 50 条
  • [31] Aggregating cost data from multicenter clinical trials: An incremental cost-effectiveness elasticity approach
    Tano, BD
    Stanford, RH
    Pathak, DS
    VALUE IN HEALTH, 2004, 7 (03) : 303 - 303
  • [32] THE COST-EFFECTIVENESS OF AURANOFIN - RESULTS OF A RANDOMIZED CLINICAL-TRIAL
    THOMPSON, MS
    READ, JL
    HUTCHINGS, HC
    PATERSON, M
    HARRIS, ED
    JOURNAL OF RHEUMATOLOGY, 1988, 15 (01) : 35 - 42
  • [33] Missing data in trial-based cost-effectiveness analysis: the current state of play
    Noble, Sian Marie
    Hollingworth, William
    Tilling, Kate
    HEALTH ECONOMICS, 2012, 21 (02) : 187 - 200
  • [34] Missing data in trial-based cost-effectiveness analysis: a review of the current practice
    Leurent, Baptiste
    Gomes, Manuel
    Carpenter, James
    TRIALS, 2017, 18
  • [35] USING COST-EFFECTIVENESS ANALYSIS TO DEFINE THE CLINICAL-SIGNIFICANCE OF EFFECTIVENESS RATES IN THE PLANNING STAGES OF A CLINICAL-TRIAL
    DETSKY, AS
    MEDICAL DECISION MAKING, 1983, 3 (03) : 356 - 356
  • [36] Making the leap from cost analysis to cost-effectiveness
    Pennington, Mark
    Vernazza, Chris
    Heasman, Peter
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2009, 36 (08) : 667 - 668
  • [38] Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial-Based Cost-Effectiveness Data
    Achana, Felix
    Gallacher, Daniel
    Oppong, Raymond
    Kim, Sungwook
    Petrou, Stavros
    Mason, James
    Crowther, Michael
    MEDICAL DECISION MAKING, 2021, 41 (06) : 667 - 684
  • [39] Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial
    Michaud, Tzeyu L.
    Wilson, Kathryn E.
    Katula, Jeffrey A.
    You, Wen
    Estabrooks, Paul A.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2023, 13 (07) : 501 - 510
  • [40] Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care: A Secondary Analysis of a Cluster Randomized Clinical Trial
    Michalowsky, Bernhard
    Blotenberg, Iris
    Platen, Moritz
    Teipel, Stefan
    Kilimann, Ingo
    Portacolone, Elena
    Bohlken, Jens
    Raedke, Anika
    Buchholz, Maresa
    Scharf, Annelie
    Muehlichen, Franka
    Xie, Feng
    Thyrian, Jochen Rene
    Hoffmann, Wolfgang
    JAMA NETWORK OPEN, 2024, 7 (07) : e2419282